Home Featured

Featured

Here Are Two Biotechs With Catalysts Next Week

- October 26, 2016

Market Morning: Day Off Doesn’t Help Wall Street, Tariffs Failling, Costco Signalling Inflation

Here’s What’s So Important About The bluebird bio Inc (NASDAQ:BLUE) Data

Here’s What To Look Out For In The Upcoming ProNAi Therapeutics Inc (NASDAQ:DNAI) Data

What Will Retrophin Inc (NASDAQ:RTRX) Get For Its Money On A Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Deal?

End Of Era For South Korea’s Exchange And First Ever Platform...

Blockhain Tech - November 12, 2018 0

Market Morning: Tariff Deadline Lifeline, Brexit Vote Postponed, Fannie & Freddie,...

ME Staff - February 25, 2019 0

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

ME Staff - December 15, 2025 0

Biotech Movers: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) and pSivida Corp. (NASDAQ:PSDV)

- June 14, 2017 0

Market Morning: Khashoggi Tale Threatens Oil Stability, S&P 500 Weaker Than...

ME Staff - October 17, 2018 0

Here’s Why The Chinese Rights Deal Is Important For Morphosys Ag...

- December 1, 2017 0

Three Biotech Updates with Catalysts: Aclaris Therapeutics Inc (NASDAQ:ACRS), Inotek Pharmaceuticals...

ME Staff - March 24, 2016 0

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Looks Good For A Recovery

- December 28, 2016 0

Why The Zika News Might Not Be So Great For Conatus...

- August 30, 2016 0

Market Morning: Commodities Climb, Yield Curve Inverts, Rioters Win, Big Tobacco...

ME Staff - December 4, 2018 0

12 3...147 Page 1 of 147

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 26, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 4, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 15, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Featured

Here Are Two Biotechs With Catalysts Next Week

Market Morning: Day Off Doesn’t Help Wall Street, Tariffs Failling, Costco Signalling Inflation

Here’s What’s So Important About The bluebird bio Inc (NASDAQ:BLUE) Data

Here’s What To Look Out For In The Upcoming ProNAi Therapeutics Inc (NASDAQ:DNAI) Data

What Will Retrophin Inc (NASDAQ:RTRX) Get For Its Money On A Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Deal?

End Of Era For South Korea’s Exchange And First Ever Platform...

Market Morning: Tariff Deadline Lifeline, Brexit Vote Postponed, Fannie & Freddie,...

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Biotech Movers: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) and pSivida Corp. (NASDAQ:PSDV)

Market Morning: Khashoggi Tale Threatens Oil Stability, S&P 500 Weaker Than...

Here’s Why The Chinese Rights Deal Is Important For Morphosys Ag...

Three Biotech Updates with Catalysts: Aclaris Therapeutics Inc (NASDAQ:ACRS), Inotek Pharmaceuticals...

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Looks Good For A Recovery

Why The Zika News Might Not Be So Great For Conatus...

Market Morning: Commodities Climb, Yield Curve Inverts, Rioters Win, Big Tobacco...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY